Skip to main content

Table 4 Multivariate analysis of variables associated with overall survival in patients undergoing repeat TACE

From: Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Overall cohort n = 292

    

Variable

Hazard Ratio

Lower 95% CI

Higher 95% CI

P value

Baseline tumour number, 1, 2,3, > 3

1.18

1.03

1.36

0.020

Bilirubin post TACE 1

1.02

1.00

1.03

0.007

AFP ≥ 200 ng/ml post TACE 1

2.13

1.34

3.40

0.001

Decompensation post TACE 2

4.50

1.86

10.89

0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us